AstraZeneca chief attacks Pfizer’s £63bn takeover bid

Deputy business editor

AstraZeneca's chief executive has launched a staunch attack on Pfizer’s £63bn takeover plan, saying it would jeopardise its “fragile” but ambitious drug discovery programme.

Pascal Soriot declared the company would grow annual sales to more than $45bn by 2023 from the current $25.7bn thanks largely to its pipeline of new medicines being developed. It was just that process of creating new drugs that would be jeopardised by a takeover, he said.

“I have been through enough mergers to known a company is not a machine. It is a group of people. If you disrupt their work you can really have a negative impact very quickly.”

AstraZeneca has gone from a position of having 57 drugs in 2012 to 84 now, as it has moved quickly to boost its development programme. Analysts say that, as well as the UK tax status, is what attracted Pfizer to make its bid.

Mr Soriot said: “Our people are very experienced, motivated and excited about what we are doing. We believe we can make an impact on medicine at this time. We have recruited very talented people. When you do this you really want to remain focused on the job at hand. "

He added: "Any distraction, any disruption, could have a negative impact on our ability to develop these products. A pipeline is something that is very fragile. That is why we believe we are better off focused on what we are doing.”

His view chimes with those of many scientists who have spoken out against the huge disruption a takeover of one of Britain’s two key pharmaceuticals champions could have.

Dr Scott Gottlieb, an adviser to pharmaceuticals companies and  resident fellow at the American Enterprise Institute, said: “You get really fundamental product breakthroughs when you have small groups of scientists working together on new areas of science over a period of many years. When companies do these mergers, it can break up these teams and break up the continuity.”

Mr Soriot said AstraZeneca’s shareholders had been supportive so far, adding: "We are in a race with many of our competitors to bring our products to the marketplace as quickly as possible. Anything that creates disruption has the potential to destroy value."

He was speaking just hours after the chief executive of top 10 AstraZeneca shareholder Aberdeen Asset Management backed the Labour leader Ed Miliband’s calls for a public interest investigation into the deal.

Aberdeen chief executive Martin Gilbert told The Independent: “AstraZeneca’s management has done a good job refocusing the business and as far as we’re concerned remaining independent remains a viable outcome.

“We do have to look at this in UK terms because it is so important for our research and development. It’s got to be about more than tax benefits.”

Earlier, he told the BBC: “Pfizer unfortunately has this reputation of being ruthless cost-cutters.”

Mr Soriot added that speed of decisionmaking was critical to bringing new drugs to market – a fleetness of foot that could be disrupted by a massive merger.

However, he declined to get pulled into the increasingly tense political atmosphere around the deal, although he acknowledged that he had been asked to participate in MPs’ select committee hearings. Both the business and science committees yesterday confirmed they would be conducting meetings with the industry including representatives from both Pfizer and AstraZeneca.

Start your day with The Independent, sign up for daily news emails
ebooks
ebooksA special investigation by Andy McSmith
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Financial Adviser

£20000 - £60000 per annum: Recruitment Genius: Are you recently QCA Level 4 qu...

SThree: Graduate Recruitment Resourcer

£20000 - £22500 per annum + OTE £30K: SThree: SThree Group have been well esta...

Guru Careers: Application Support Analyst / 1st Line Support

£25 - 30k: Guru Careers: We are seeking an Application Support Analyst / 1st L...

Guru Careers: .NET Developer / Web Developer

£45K - £55K (DOE) + Benefits: Guru Careers: We are seeking a full stack .NET D...

Day In a Page

Not even the 'putrid throat' could stop the Ross Poldark swoon-fest'

Not even the 'putrid throat' could stop the Ross Poldark swoon-fest'

How a costume drama became a Sunday night staple
Miliband promises no stamp duty for first-time buyers as he pushes Tories on housing

Miliband promises no stamp duty for first-time buyers

Labour leader pushes Tories on housing
Aviation history is littered with grand failures - from the the Bristol Brabazon to Concorde - but what went wrong with the SuperJumbo?

Aviation history is littered with grand failures

But what went wrong with the SuperJumbo?
Fear of Putin, Islamists and immigration is giving rise to a new generation of Soviet-style 'iron curtains' right across Europe

Fortress Europe?

Fear of Putin, Islamists and immigration is giving rise to a new generation of 'iron curtains'
Never mind what you're wearing, it's what you're reclining on

Never mind what you're wearing

It's what you're reclining on that matters
General Election 2015: Chuka Umunna on the benefits of immigration, humility – and his leader Ed Miliband

Chuka Umunna: A virus of racism runs through Ukip

The shadow business secretary on the benefits of immigration, humility – and his leader Ed Miliband
Yemen crisis: This exotic war will soon become Europe's problem

Yemen's exotic war will soon affect Europe

Terrorism and boatloads of desperate migrants will be the outcome of the Saudi air campaign, says Patrick Cockburn
Marginal Streets project aims to document voters in the run-up to the General Election

Marginal Streets project documents voters

Independent photographers Joseph Fox and Orlando Gili are uploading two portraits of constituents to their website for each day of the campaign
Game of Thrones: Visit the real-life kingdom of Westeros to see where violent history ends and telly tourism begins

The real-life kingdom of Westeros

Is there something a little uncomfortable about Game of Thrones shooting in Northern Ireland?
How to survive a social-media mauling, by the tough women of Twitter

How to survive a Twitter mauling

Mary Beard, Caroline Criado-Perez, Louise Mensch, Bunny La Roche and Courtney Barrasford reveal how to trounce the trolls
Gallipoli centenary: At dawn, the young remember the young who perished in one of the First World War's bloodiest battles

At dawn, the young remember the young

A century ago, soldiers of the Empire – many no more than boys – spilt on to Gallipoli’s beaches. On this 100th Anzac Day, there are personal, poetic tributes to their sacrifice
Dissent is slowly building against the billions spent on presidential campaigns – even among politicians themselves

Follow the money as never before

Dissent is slowly building against the billions spent on presidential campaigns – even among politicians themselves, reports Rupert Cornwell
Samuel West interview: The actor and director on austerity, unionisation, and not mentioning his famous parents

Samuel West interview

The actor and director on austerity, unionisation, and not mentioning his famous parents
General Election 2015: Imagine if the leading political parties were fashion labels

Imagine if the leading political parties were fashion labels

Fashion editor, Alexander Fury, on what the leaders' appearances tell us about them
Phumzile Mlambo-Ngcuka: Home can be the unsafest place for women

Phumzile Mlambo-Ngcuka: Home can be the unsafest place for women

The architect of the HeForShe movement and head of UN Women on the world's failure to combat domestic violence